Simtra BioPharma Solutions Appoints Dr. Mike Schäfers as Chief Commercial Officer

Dr. Schäfers brings extensive experience from leadership roles at LTS Lohmann Therapie-Systeme AG, Aenova Holding GmbH, and West Pharmaceutical Services. At LTS, Dr. Schäfers served as Chief Commercial Officer and managed a global team across Germany, the U.S., and China. Throughout his career, he has successfully developed strategies that significantly contributed to business growth, managed business collaborations as well as partnerships and led key acquisitions and integration activities...
Comunicato Precedente

next
Comunicato Successivo

next
PARSIPPANY, (informazione.it - comunicati stampa - salute e benessere)

Dr. Schäfers brings extensive experience from leadership roles at LTS Lohmann Therapie-Systeme AG, Aenova Holding GmbH, and West Pharmaceutical Services. At LTS, Dr. Schäfers served as Chief Commercial Officer and managed a global team across Germany, the U.S., and China. Throughout his career, he has successfully developed strategies that significantly contributed to business growth, managed business collaborations as well as partnerships and led key acquisitions and integration activities.

“Dr. Mike Schäfers has a unique blend of strategic insight and hands-on operational expertise,” said Franco Negron, CEO of Simtra BioPharma Solutions. “Mike understands the complexities of our industry and will be a key driver in our efforts to enhance our market presence and deliver exceptional value to our clients.”

“I am thrilled to join Simtra BioPharma Solutions at such an exciting time in the company's growth,” said Dr. Mike Schäfers. “I look forward to working with the talented team here to continue building on Simtra's success and to contribute to the company's ongoing mission of excellence in the CDMO space.”

Holding a Ph.D. in Inorganic Chemistry from Ruhr University Bochum, Dr. Schäfers has also completed executive leadership programs and is an active member of industry associations.

For more information, please contact: Rhonda Luniak, Director of Communications, Simtra BioPharma Solutions, [email protected], 303.406.8743

For more information about Simtra BioPharma Solutions, please visit www.simtra.com

LinkedIn: https://www.linkedin.com/company/simtra-biopharma-solutions/

About Simtra BioPharma Solutions:

As the premier, independently owned Contract Development Manufacturing Organization with more than 65 years of sterile injectable manufacturing expertise, Simtra BioPharma Solutions offers world-class cGMP sterile fill and finish, technical expertise, quality service, and a uniquely collaborative approach to support our customers' strategic objectives.

Biotech and pharmaceutical companies partner with us when they need to take their molecule to market, whether launching an innovation globally, improving a formulation, or proactively mitigating risk to grow their business.

Our teams of tenured experts deliver tailored, flexible solutions to help our customers consistently fulfill their product goals at the highest quality, so they get in the hands of the patients who need them most.


Per maggiori informazioni
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Slide ShowSlide Show
Non disponibili